Many investors criticised the controversial possibility of offering financing of six times Ebitda in the deal backing Cinven’s £800m buyout of French healthcare group Sebia International — claiming the market was still too fragile.
However, a slight majority (43%) of voters in the poll were unphased by this, ...Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: subs@globalcapital.com
Corporate access
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.
